Australian Alzheimer’s study

Wednesday, 20 June, 2007

A major Australian study to better understand Alzheimer's disease has started.

The $10 million Australian Imaging, Biomarker and Lifestyle (AIBL) Flagship Study of Ageing has brought together leading Australian researchers for a three-year study to improve understanding of the causes and diagnosis of the disease, to examine lifestyle and diet factors that may influence the onset of Alzheimer's and to help develop preventative strategies.

It will be one of the world's largest studies of its type involving positron emission tomography (PET) scans using Pittsburgh Compound-B (PIB), a PET amyloid-imaging agent. The scans are used to show differences between the brains of Alzheimer's patients and healthy volunteers.

The study was established by the CSIRO-led Preventative Health National Research Flagship, and involves Edith Cowan University, the University of Melbourne, Neurosciences Australia and the Mental Health Research Institute of Victoria.

Related News

Applications open for Elevate: Boosting women in STEM

Elevate will award up to 500 undergraduate and postgraduate scholarships to women in science,...

Beckman Coulter Life Sciences appoints Suzanne Foster as President

A seasoned executive, Foster brings more than 25 years of experience in the healthcare industry.

National biotech incubator announces $17m in project funding

CUREator supports and accelerates the development of Australian biotech innovations, and has...

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd